COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Dose Finding Study of Once or Twice Weekly IMMU-130 in Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01605318
Recruitment Status : Withdrawn (No patients are enrolled in any studies conducted under this IND)
First Posted : May 24, 2012
Last Update Posted : May 12, 2020
Information provided by (Responsible Party):
Immunomedics, Inc.